All Phenotypes Igha<tm1(Myc)Janz> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
ht1	Igha^tm1(Myc)Janz/Igha⁺	involves: 129S1/Sv * C57BL/6	MGI:3046402
cx2	Igha^tm1(Myc)Janz/Igha⁺ Tg(Tnfsf13b)1Fma/0	involves: 129S1/Sv * C57BL/6 * DBA/2J	MGI:4840220
cx3	Igha^tm1(Myc)Janz/Igha⁺ Tg(Igk-V21-Bax)1967Bvn/0	involves: 129S1/Sv * C57BL/6 * FVB/N	MGI:3046405

Allelic Composition	Igha^tm1(Myc)Janz/Igha⁺
Genetic Background	involves: 129S1/Sv * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igha^tm1(Myc)Janz mutation (1 available); any Igha mutation (16 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased B cell derived lymphoma incidence ( J:90901 )

• transgenic mice display an increased incidence (9.3%) of B cell derived lymphomas with a mean onset of 330 days

hematopoietic system

increased B cell apoptosis ( J:90901 )

• B cell apoptosis is increased about 4.5 fold compared to normal B cells

increased B cell proliferation ( J:90901 )

• B cells proliferate about 2.5 - 3 times faster compared to normal mice

increased plasma cell number ( J:90901 )

• B220^hiCD138⁺, putative plasmablasts, numbers are increased in the bone marrow of transgenic mice

immune system

increased B cell apoptosis ( J:90901 )

• B cell apoptosis is increased about 4.5 fold compared to normal B cells

increased B cell proliferation ( J:90901 )

• B cells proliferate about 2.5 - 3 times faster compared to normal mice

increased plasma cell number ( J:90901 )

• B220^hiCD138⁺, putative plasmablasts, numbers are increased in the bone marrow of transgenic mice

cellular

increased B cell apoptosis ( J:90901 )

• B cell apoptosis is increased about 4.5 fold compared to normal B cells

increased B cell proliferation ( J:90901 )

• B cells proliferate about 2.5 - 3 times faster compared to normal mice

Allelic Composition	Igha^tm1(Myc)Janz/Igha⁺ Tg(Tnfsf13b)1Fma/0
Genetic Background	involves: 129S1/Sv * C57BL/6 * DBA/2J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Igha^tm1(Myc)Janz mutation (1 available); any Igha mutation (16 available)
Tg(Tnfsf13b)1Fma mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:166158 )

• median lifespan of mice with leukemia is 10 months

hematopoietic system

enlarged spleen ( J:166158 )

• splenomegaly is obvious in males after 4 months of age

increased lymphocyte cell number ( J:166158 )

• males develop lymphocytosis at 3 months of age

increased B cell number ( J:166158 )

• males exhibit an increase in blood B-cell number, with an expansion of the CD5+CD3-B220^low IgM^low B-cell population in blood and spleens

increased mature B cell number ( J:166158 )

• B-cell increase results from a monoclonal expansion of mature B cell-like cells

increased spleen white pulp amount ( J:166158 )

• 8 month old spleens of males exhibit enlarged white pulp with loss of normal splenic architecture resulting from a diffuse infiltration of mature lymphocytes

immune system

enlarged spleen ( J:166158 )

• splenomegaly is obvious in males after 4 months of age

increased lymphocyte cell number ( J:166158 )

• males develop lymphocytosis at 3 months of age

increased B cell number ( J:166158 )

• males exhibit an increase in blood B-cell number, with an expansion of the CD5+CD3-B220^low IgM^low B-cell population in blood and spleens

increased mature B cell number ( J:166158 )

• B-cell increase results from a monoclonal expansion of mature B cell-like cells

increased spleen white pulp amount ( J:166158 )

• 8 month old spleens of males exhibit enlarged white pulp with loss of normal splenic architecture resulting from a diffuse infiltration of mature lymphocytes

neoplasm

increased chronic lymphocytic leukemia incidence ( J:166158 )

• mutants, mainly males, develop a CD5+ B-cell lymphoproliferative disease by 8 months of age that resembles human chronic lymphocytic leukemia

• male mice exhibit increased splenic ¹⁸F-labeled 2-fluoro-2-deoxy-D-glucose (FDG) uptake suggesting elevated leukemic cell metabolism

growth/size/body

enlarged spleen ( J:166158 )

• splenomegaly is obvious in males after 4 months of age

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
chronic lymphocytic leukemia		DOID:1040	OMIM:109543 OMIM:151400 OMIM:609630 OMIM:612557 OMIM:612558 OMIM:612559	J:166158

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

growth/size/body

enlarged spleen ( J:90901 )

• 8 week old double transgenic exhibit splenomegaly with massive accumulation of plasma cells in extrafollicular areas

mortality/aging

decreased tumor-free survival time ( J:90901 )

• survival of double transgenics is markedly decreased as a result of malignant plasma cell tumors

neoplasm

increased leukemia incidence ( J:90901 )

• in some cases plasma cell leukemia is seen

increased plasmacytoma incidence ( J:90901 )

• malignant plasma cell tumors develop rapidly with a mean onset of 135 days, are fully penetrant, proliferate vigorously, occur in multiple tissues including the spleen, bone marrow, and lymph nodes, and may have monocentric or multicentric origins

• bone sections from double transgenic mice with less advanced tumors show multifocal lesions of aberrant pleomorphic plasma cells next to diminished of dissolved osseous trabeculae

• pathalogical fractures of the long bones are seen in some double transgenic mice

hematopoietic system

abnormal B cell apoptosis ( J:90901 )

• B cell apoptosis is increased compared to normal B cells but decreased compared to B cells from Igh-2^tm1Janz single transgenics

enlarged spleen ( J:90901 )

• 8 week old double transgenic exhibit splenomegaly with massive accumulation of plasma cells in extrafollicular areas

abnormal plasma cell morphology ( J:90901 )

• plasma cells participate in cell cycling unlike in normal mice

increased plasma cell number ( J:90901 )

• the bone marrow and spleen contain on average 42% and 34% plasma cells, respectively, compared to less than 2% in normal mice

increased IgG level ( J:90901 )

• elevation of IgG accompanied the increase in plasma cell numbers

increased IgM level ( J:90901 )

• elevation of IgM accompanied the increase in plasma cell numbers

immune system

abnormal B cell apoptosis ( J:90901 )

• B cell apoptosis is increased compared to normal B cells but decreased compared to B cells from Igh-2^tm1Janz single transgenics

enlarged spleen ( J:90901 )

• 8 week old double transgenic exhibit splenomegaly with massive accumulation of plasma cells in extrafollicular areas

abnormal plasma cell morphology ( J:90901 )

• plasma cells participate in cell cycling unlike in normal mice

increased plasma cell number ( J:90901 )

• the bone marrow and spleen contain on average 42% and 34% plasma cells, respectively, compared to less than 2% in normal mice

increased IgG level ( J:90901 )

• elevation of IgG accompanied the increase in plasma cell numbers

increased IgM level ( J:90901 )

• elevation of IgM accompanied the increase in plasma cell numbers

cellular

abnormal B cell apoptosis ( J:90901 )

• B cell apoptosis is increased compared to normal B cells but decreased compared to B cells from Igh-2^tm1Janz single transgenics

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/16/2024 MGI 6.23